Home > Financial Ratios > ANUH PHARMA

ANUH PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results

ANUH PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.926.777.948.0112.17

What is the latest EV/Core EBITDA ratio of ANUH PHARMA ?

The latest EV/Core EBITDA ratio of ANUH PHARMA is 13.92 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202413.92
Mar20236.77
Mar20227.94
Mar20218.01
Mar202012.17

How is EV/Core EBITDA of ANUH PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 13.92
105.61
Mar2023 6.77
-14.74
Mar2022 7.94
-0.87
Mar2021 8.01
-34.18
Mar2020 12.17 -

Other Financial Ratios of ANUH PHARMA


Compare EV/Core EBITDA ratio of peers of ANUH PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANUH PHARMA ₹825.1 Cr 7.4% 1.2% -30.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,293.0 Cr -1.7% 5.5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹139,692.0 Cr -5.2% -4.6% 49% Stock Analytics
CIPLA ₹111,807.0 Cr -4.2% -2.4% -3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,404.0 Cr 1.6% 8.4% 26.9% Stock Analytics
DR REDDYS LABORATORIES ₹90,843.0 Cr -5.5% -3.4% -9.4% Stock Analytics


ANUH PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ANUH PHARMA

7.4%

1.2%

-30.3%

SENSEX

-5.5%

0.2%

-1%


You may also like the below Video Courses